Share on StockTwits

Perrigo Company PLC (NASDAQ:PRGO) EVP John T. Hendrickson sold 2,533 shares of Perrigo Company PLC stock in a transaction dated Monday, August 25th. The shares were sold at an average price of $148.44, for a total value of $375,998.52. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

PRGO has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of Perrigo Company PLC in a research note on Monday, August 18th. They now have a $156.00 price target on the stock. Separately, analysts at B. Riley upgraded shares of Perrigo Company PLC from a “neutral” rating to a “buy” rating in a research note on Friday, August 15th. They now have a $180.00 price target on the stock, up previously from $157.00. Finally, analysts at Jefferies Group raised their price target on shares of Perrigo Company PLC from $160.00 to $176.00 in a research note on Friday, August 15th. They now have a “buy” rating on the stock. Three analysts have rated the stock with a hold rating, eight have issued a buy rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $166.92.

Perrigo Company PLC (NASDAQ:PRGO) traded up 0.09% during mid-day trading on Tuesday, hitting $148.12. 560,404 shares of the company’s stock traded hands. Perrigo Company PLC has a 52 week low of $115.94 and a 52 week high of $168.39. The stock has a 50-day moving average of $149.7 and a 200-day moving average of $148.. The company has a market cap of $19.821 billion and a P/E ratio of 83.61.

Perrigo Company PLC (NASDAQ:PRGO) last released its earnings data on Thursday, August 14th. The company reported $1.74 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.55 by $0.19. The company had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.09 billion. On average, analysts predict that Perrigo Company PLC will post $7.39 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, September 16th. Shareholders of record on Friday, August 29th will be given a dividend of $0.105 per share. This represents a $0.42 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date of this dividend is Wednesday, August 27th.

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (NASDAQ:PRGO) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.